Company Name: Pieris Pharmaceuticals, Inc.

Pieris Pharmaceuticals, Inc. is a clinical stage biotechnology company. The company is engaged in the discovery and development of Anticalin-based therapeutics using its proprietary Anticalin® technology.  The company’s developmental pipeline includes product candidates for anemia, asthma and immuno-oncology.  In addition to developing its proprietary programs, the company also collaborates with other companies. 

Ticker Symbol: PIRS (NASDAQ)

Company Website: www.pieris.com

Headquarters: Boston, MA